To hear about similar clinical trials, please enter your email below
Trial Title:
A Prospective Study of Surgical Treatment Strategies for Chordoma
NCT ID:
NCT05707767
Condition:
Chordoma of Spine
Surgery
Conditions: Official terms:
Chordoma
Conditions: Keywords:
chordoma
Study type:
Interventional
Study phase:
N/A
Overall status:
Unknown status
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Resection surgery
Description:
Patients undergo resection surgery in our hospital.
Arm group label:
Chordoma Patients
Summary:
Chordoma is a rare but locally invasive cancer that arises from the embryonic notochord.
Total resection is challenging in mobile spine because of the complex anatomy and bone
invasion.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Between the ages of 18 and 70 ys,
- With a diagnosis of chordoma confirmed by pathology,
- Undergone surgical treatment in our hospital,
- Available for clinical follow-up and agree to long-term clinical follow-up and sign
informed consent.
Exclusion Criteria:
- Suffer from other tumors,
- Suffer from cardiovascular disease, cerebrovascular disease, or immune system
disease.
Gender:
All
Minimum age:
18 Years
Maximum age:
70 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Xuanwu Hospital, Capital Medical University
Address:
City:
Beijing
Zip:
100000
Country:
China
Status:
Recruiting
Contact:
Last name:
Zan Chen, MD. PHD.
Phone:
18131166269
Email:
chenzan66@163.com
Start date:
February 1, 2023
Completion date:
September 30, 2024
Lead sponsor:
Agency:
Xuanwu Hospital, Beijing
Agency class:
Other
Source:
Xuanwu Hospital, Beijing
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05707767
